Back | Next |
home / stock / evok / evok message board
Subject | By | Source | When |
---|---|---|---|
Filled gap up now on a slow | Runners123 | investorshub | 04/29/2022 3:08:45 PM |
Bs games!! It will go back up. Lol | JJL | investorshub | 04/28/2022 9:26:49 PM |
Omg what the hell why did this drop | europtiger | investorshub | 04/28/2022 6:24:01 PM |
I sold in the premarketr/s 1/12 next.. | THEMASTERS_SON | investorshub | 04/28/2022 1:59:18 PM |
Proven product. Proven revenues. And now FDA has granted exclusivity. This | Hercules1 | investorshub | 04/28/2022 1:25:23 PM |
Stock is an unbelievable value with this dip. This | Hercules1 | investorshub | 04/28/2022 1:23:28 PM |
LOAD UP.Eversana buyout might happen | THEMASTERS_SON | investorshub | 04/28/2022 12:28:02 AM |
Makes sense. | JJL | investorshub | 04/27/2022 8:26:22 PM |
,,,,,,,Ok nowww AH you should buy.62 | THEMASTERS_SON | investorshub | 04/27/2022 8:20:32 PM |
$EVOK: i tripled my position in this stock. | Hercules1 | investorshub | 04/27/2022 6:49:04 PM |
I'll take my .66!! | JJL | investorshub | 04/27/2022 5:01:22 PM |
,,,,,,,,Wait to buy after the meeting. | THEMASTERS_SON | investorshub | 04/27/2022 3:09:58 PM |
Fantastic dip buy opportunity. This stock is not going | Hercules1 | investorshub | 04/27/2022 2:44:54 PM |
I hear you,,,,God bless you brother. HANG IN | THEMASTERS_SON | investorshub | 04/27/2022 10:23:29 AM |
,,,,,,,GOOD MORNING! ROCK N ROLL>>>>$2+ | THEMASTERS_SON | investorshub | 04/27/2022 10:03:20 AM |
1.01 ^ 0.15 (17.44%) | TheFinalCD | investorshub | 04/27/2022 9:06:32 AM |
never been diagnosed.. use to run to | saigai | investorshub | 04/26/2022 10:03:37 PM |
znewcar1: EVOK 118% v214M c.860 f32,9M H1.4 gapNcrap | znewcar1 | investorshangout | 04/26/2022 9:46:45 PM |
Wow Ill take 25k 70s AH | THEMASTERS_SON | investorshub | 04/26/2022 9:34:00 PM |
Really??? Were you diagnosed recently | THEMASTERS_SON | investorshub | 04/26/2022 9:32:45 PM |
News, Short Squeeze, Breakout and More Instantly...
SOLANA BEACH, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced it will host a virtua...
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily ...
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that Matthew J. D’...